In an orthotopic model of pancreatic cancer, oncogenic KRASG12D signaling pathways were shown to drive an immunosuppressive environment by GM-CSF-mediated recruitment of suppressive myeloid populations, which could affect the function of effector CD8 T cells (46). The gene discussed is CD8A; the disease is pancreatic neoplasm.